China Biologic Products Inc. (NASDAQ:CBPO)

Wednesday, November 4, 2015 | Web News
Third Quarter 2015 Financial Results Total sales in the third quarter of 2015 increased by 14.4% to $78.8 million from $68.9...
Tuesday, October 20, 2015 | Web News
BEIJING, October 20, 2015 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the...
Tuesday, September 8, 2015 | Web News
BEIJING, September 8, 2015 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the...

At least one FIE exists in the corporate structure

China Biologic Products, Inc., through its indirect majority-owned subsidiary, Shandong Taibang, is currently the only plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province with a population of 93 million. The company is engaged primarily in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China.

Web site: http://www.ctbb.com.cn/

Last updated March 17, 2008